Skip to content

Insider · CIK 0001301582

Ranker Philip C

Reports to the SEC for 2 companies · REDMOND, WA

Transactions

16

Companies

2

Filings

14

CIK

0001301582

Forms 4 and 5

Insider transactions

16 trades
DateCompanyValue
2018-05-02ATRXAdhera Therapeutics, Inc. · Options to purchase common stockA Award—
2018-04-16ATRXAdhera Therapeutics, Inc. · Series E Convertible Preferred StockA Award+$90K
2018-04-16ATRXAdhera Therapeutics, Inc. · Warrants to Purchase Common StockA Award—
2018-01-03ATRXAdhera Therapeutics, Inc. · Options to purchase common stockA Award—
2017-01-03ATRXAdhera Therapeutics, Inc. · Options to purchase common stockA Award—
2016-11-15ATRXAdhera Therapeutics, Inc. · Options to purchase common stockA Award—
2016-01-04ATRXAdhera Therapeutics, Inc. · Options to purchase common stockA Award—
2015-01-06ATRXAdhera Therapeutics, Inc. · Options to purchase common stockA Award—
2014-09-15ATRXAdhera Therapeutics, Inc. · Options to purchase common stockA Award—
2014-01-01ATRXAdhera Therapeutics, Inc.A Award—
2011-09-07ATRXAdhera Therapeutics, Inc. · Marina Biotech, Inc. Common Stock OptionsA Award+$5,500
2009-08-21IMARX THERAPEUTICS INCA Award—
2007-12-18IMARX THERAPEUTICS INCStock OptionA Award—
2007-07-02ATRXAdhera Therapeutics, Inc.F Tax Payment−$2,108.16
2006-01-01ATRXAdhera Therapeutics, Inc. · Nastech Pharmaceutical Company Inc Stock OptionsA Award+$296K
2006-01-01ATRXAdhera Therapeutics, Inc.A Award—

Recent filings

14

Companies

2

Address

12277 134TH COURT NE, SUITE 202

REDMOND, WA, 98052